Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah P Merke

Showing results (91-100 of 112) with videos related to

Pageof 12
Sort By:
The Journal of Clinical Endocrinology and Metabolism|December 13, 2024
Adult Height Following Prepubertal Treatment With Antiandrogen, Aromatase Inhibitor, and Reduced Hydrocortisone in CAHDeborah P Merke, Ashwini Mallappa, Megan Parker, et al.
The Journal of Clinical Endocrinology and Metabolism|June 19, 2021
Tildacerfont in Adults With Classic Congenital Adrenal Hyperplasia: Results from Two Phase 2 StudiesKyriakie Sarafoglou, Chris N Barnes, Michael Huang, et al.
The Journal of Clinical Endocrinology and Metabolism|January 14, 2016
Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice GuidelineStefan R Bornstein, Bruno Allolio, Wiebke Arlt, et al.
The Journal of Clinical Endocrinology and Metabolism|January 4, 2013
Tenascin-X haploinsufficiency associated with Ehlers-Danlos syndrome in patients with congenital adrenal hyperplasiaDeborah P Merke, Wuyan Chen, Rachel Morissette, et al.
International Journal of Molecular Sciences|March 13, 2024
Evidence of the Role of Inflammation and the Hormonal Environment in the Pathogenesis of Adrenal Myelolipomas in Congenital Adrenal HyperplasiaVipula Kolli, Emily Frucci, Isabela Werneck da Cunha, et al.
The Journal of Clinical Endocrinology and Metabolism|June 27, 2020
A Phase 2, Multicenter Study of Nevanimibe for the Treatment of Congenital Adrenal HyperplasiaDiala El-Maouche, Deborah P Merke, Maria G Vogiatzi, et al.
The Journal of Clinical Endocrinology and Metabolism|December 16, 2014
A phase 2 study of Chronocort, a modified-release formulation of hydrocortisone, in the treatment of adults with classic congenital adrenal hyperplasiaAshwini Mallappa, Ninet Sinaii, Parag Kumar, et al.
The Journal of Clinical Endocrinology and Metabolism|November 16, 2016
Modified-Release and Conventional Glucocorticoids and Diurnal Androgen Excretion in Congenital Adrenal HyperplasiaChristopher M Jones, Ashwini Mallappa, Nicole Reisch, et al.
The Journal of Clinical Endocrinology and Metabolism|October 2, 2018
Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice GuidelinePhyllis W Speiser, Wiebke Arlt, Richard J Auchus, et al.
International Journal of Pediatric Endocrinology|October 29, 2010
A Summary of the Endocrine Society Clinical Practice Guidelines on Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase DeficiencyPhyllis W Speiser, Ricardo Azziz, Laurence S Baskin, et al.
Pageof 12

Showing results (91-100 of 112) with videos related to

Sort By:
Pageof 12
The Journal of Clinical Endocrinology and Metabolism|December 13, 2024
Adult Height Following Prepubertal Treatment With Antiandrogen, Aromatase Inhibitor, and Reduced Hydrocortisone in CAHDeborah P Merke, Ashwini Mallappa, Megan Parker, et al.
The Journal of Clinical Endocrinology and Metabolism|June 19, 2021
Tildacerfont in Adults With Classic Congenital Adrenal Hyperplasia: Results from Two Phase 2 StudiesKyriakie Sarafoglou, Chris N Barnes, Michael Huang, et al.
The Journal of Clinical Endocrinology and Metabolism|January 14, 2016
Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice GuidelineStefan R Bornstein, Bruno Allolio, Wiebke Arlt, et al.
The Journal of Clinical Endocrinology and Metabolism|January 4, 2013
Tenascin-X haploinsufficiency associated with Ehlers-Danlos syndrome in patients with congenital adrenal hyperplasiaDeborah P Merke, Wuyan Chen, Rachel Morissette, et al.
International Journal of Molecular Sciences|March 13, 2024
Evidence of the Role of Inflammation and the Hormonal Environment in the Pathogenesis of Adrenal Myelolipomas in Congenital Adrenal HyperplasiaVipula Kolli, Emily Frucci, Isabela Werneck da Cunha, et al.
The Journal of Clinical Endocrinology and Metabolism|June 27, 2020
A Phase 2, Multicenter Study of Nevanimibe for the Treatment of Congenital Adrenal HyperplasiaDiala El-Maouche, Deborah P Merke, Maria G Vogiatzi, et al.
The Journal of Clinical Endocrinology and Metabolism|December 16, 2014
A phase 2 study of Chronocort, a modified-release formulation of hydrocortisone, in the treatment of adults with classic congenital adrenal hyperplasiaAshwini Mallappa, Ninet Sinaii, Parag Kumar, et al.
The Journal of Clinical Endocrinology and Metabolism|November 16, 2016
Modified-Release and Conventional Glucocorticoids and Diurnal Androgen Excretion in Congenital Adrenal HyperplasiaChristopher M Jones, Ashwini Mallappa, Nicole Reisch, et al.
The Journal of Clinical Endocrinology and Metabolism|October 2, 2018
Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice GuidelinePhyllis W Speiser, Wiebke Arlt, Richard J Auchus, et al.
International Journal of Pediatric Endocrinology|October 29, 2010
A Summary of the Endocrine Society Clinical Practice Guidelines on Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase DeficiencyPhyllis W Speiser, Ricardo Azziz, Laurence S Baskin, et al.
Pageof 12